{"info": {"address1": "44370 Old Warm Springs Boulevard", "city": "Fremont", "state": "CA", "zip": "94538", "country": "United States", "phone": "510 668 0881", "website": "https://www.abvcpharma.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "ABVC BioPharma, Inc., a clinical-stage biopharmaceutical company, develops drugs and medical devices to fulfill unmet medical needs in the United States. The company is developing ABV-1501, which is in Phase II clinical trials as a combination therapy for triple negative breast cancer; ABV-1504, which has completed Phase II clinical trials for depressive disorders; ABV-1505, which is in Phase II clinical trials for adult attention deficit hyperactivity disorder; ABV-1702, which is in Phase II clinical trials to treat myelodysplastic syndromes; and ABV-1601, which is in Phase I/II clinical trials for treating depression in cancer patients. It is also developing ABV-1701 Vitargus, which is in Phase II clinical trials for the treatment of retinal detachment or vitreous hemorrhage; ABV-1519, which is in Phase I/II clinical trials for the treatment of non-small cell lung cancer; ABV-2001, an intraocular irrigation solution; ABV-2002, a corneal Storage Solution; and ABV-1703, which is in Phase II clinical trials for the treatment of metastatic pancreatic cancer. ABVC BioPharma, Inc. has a co-development agreement with Rgene Corporation and collaboration agreements with BioHopeKing Corporation and BioFirst Corporation. The company is based in Fremont, California. ABVC BioPharma, Inc. operates as a subsidiary of YuanGene Corporation.", "fullTimeEmployees": 16, "companyOfficers": [{"maxAge": 1, "name": "Mr. Eugene  Jiang", "age": 39, "title": "Chairman & Chief Business Officer", "yearBorn": 1986, "fiscalYear": 2024, "totalPay": 200000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Uttam Yashwant Patil Ph.D.", "age": 39, "title": "CEO & Interim CFO", "yearBorn": 1986, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Tsung-Shann  Jiang EMBA, Ph.D.", "age": 72, "title": "Chief Scientific Officer, Chief Strategy Officer & Director", "yearBorn": 1953, "fiscalYear": 2024, "totalPay": 200000, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 2.06, "open": 2.1, "dayLow": 2.01, "dayHigh": 2.1, "regularMarketPreviousClose": 2.06, "regularMarketOpen": 2.1, "regularMarketDayLow": 2.01, "regularMarketDayHigh": 2.1, "payoutRatio": 0.0, "beta": 0.211, "forwardPE": -4.681818, "volume": 48334, "regularMarketVolume": 48334, "averageVolume": 65291, "averageVolume10days": 53060, "averageDailyVolume10Day": 53060, "bid": 1.46, "ask": 2.59, "bidSize": 2, "askSize": 2, "marketCap": 50060240, "fiftyTwoWeekLow": 0.4, "fiftyTwoWeekHigh": 5.48, "allTimeHigh": 7165605.0, "allTimeLow": 0.343949, "priceToSalesTrailing12Months": 62.738735, "fiftyDayAverage": 2.3458, "twoHundredDayAverage": 2.40519, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 53440860, "profitMargins": 0.0, "floatShares": 20808227, "sharesOutstanding": 24301089, "sharesShort": 347329, "sharesShortPriorMonth": 377266, "sharesShortPreviousMonthDate": 1764288000, "dateShortInterest": 1767139200, "sharesPercentSharesOut": 0.0143, "heldPercentInsiders": 0.10705, "heldPercentInstitutions": 0.030439999, "shortRatio": 4.38, "shortPercentOfFloat": 0.0161, "impliedSharesOutstanding": 24301089, "bookValue": 0.514, "priceToBook": 4.007782, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -5077184, "trailingEps": -0.28, "forwardEps": -0.44, "lastSplitFactor": "1:10", "lastSplitDate": 1690243200, "enterpriseToRevenue": 66.976, "enterpriseToEbitda": -10.951, "52WeekChange": 2.869159, "SandP52WeekChange": 0.14544725, "quoteType": "EQUITY", "currentPrice": 2.06, "recommendationKey": "none", "totalCash": 257243, "totalCashPerShare": 0.011, "ebitda": -4880031, "totalDebt": 2472189, "quickRatio": 0.04, "currentRatio": 0.626, "totalRevenue": 797916, "debtToEquity": 17.058, "revenuePerShare": 0.046, "returnOnAssets": -0.17221001, "returnOnEquity": -0.47713003, "grossProfits": 797916, "freeCashflow": -1543949, "operatingCashflow": -2269398, "revenueGrowth": 1.045, "grossMargins": 1.0, "ebitdaMargins": 0.0, "operatingMargins": -1.4651899, "financialCurrency": "USD", "symbol": "ABVC", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "ABVC Biopharma, Inc.", "longName": "ABVC BioPharma, Inc.", "regularMarketChangePercent": 0.0, "regularMarketPrice": 2.06, "exchange": "NCM", "messageBoardId": "finmb_325748154", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.28, "epsForward": -0.44, "fiftyDayAverageChange": -0.28579998, "fiftyDayAverageChangePercent": -0.12183476, "twoHundredDayAverageChange": -0.34519005, "twoHundredDayAverageChangePercent": -0.14351882, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-08-03", "prevName": "American BriVision (Holding) Corporation", "nameChangeDate": "2026-01-27", "cryptoTradeable": false, "marketState": "POST", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1100097000000, "postMarketChangePercent": 0.0, "postMarketPrice": 2.06, "postMarketChange": 0.0, "regularMarketChange": 0.0, "regularMarketDayRange": "2.01 - 2.1", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 65291, "fiftyTwoWeekLowChange": 1.66, "fiftyTwoWeekLowChangePercent": 4.1499996, "fiftyTwoWeekRange": "0.4 - 5.48", "fiftyTwoWeekHighChange": -3.42, "fiftyTwoWeekHighChangePercent": -0.62408763, "fiftyTwoWeekChangePercent": 286.9159, "dividendDate": 1557273600, "earningsTimestampStart": 1754996340, "earningsTimestampEnd": 1755518400, "postMarketTime": 1769547857, "regularMarketTime": 1769547601, "corporateActions": [], "displayName": "ABVC BioPharma", "trailingPegRatio": null}, "info_ts": "2026-01-27T21:04:31.620529+00:00"}